Dr. Art Rastinehad, DO, has been named a 2026 Castle Connolly Top Doctor, marking the 12th year he has received this prestigious designation. Only 7 percent of the nation's licensed physicians are selected annually as Castle Connolly Top Doctors for their specialties in their regions. Dr. Rastinehad serves as professor of urology and radiology, vice chair of urology at Northwell's Lenox Hill Hospital, and Northwell Health System director for prostate cancer.
His clinical and research focus includes precision prostate cancer diagnosis, MRI-targeted biopsy, focal therapy, image-guided treatment, interventional urology, and prostate artery embolization for enlarged prostate/BPH. Dr. Rastinehad emphasized the significance of the recognition: "Being recognized as a Castle Connolly Top Doctor is meaningful because it reflects the trust patients and peers place in our work. My goal is to help men make clear, informed decisions about prostate cancer, enlarged prostate, and urinary symptoms by coordinating the right evaluation and the most appropriate treatment options for each individual patient." He added that precision prostate care involves matching the right patient to the right diagnosis and treatment, rather than a one-size-fits-all approach.
Dr. Rastinehad's research team has been instrumental in advancing image-guided prostate care, including early validation of MR/US fusion biopsy for prostate cancer detection in the United States. His work continues to shape prostate cancer diagnosis, focal therapy planning, minimally invasive treatment, and interventional options for men with BPH. Notably, he was the first dual fellowship-trained urologic oncologist and interventional radiologist, completing advanced training through the National Institutes of Health, the National Cancer Institute, and Northwell's North Shore University Hospital.
Key achievements include being the first to publish a series on prostate artery embolization in 2006, early validation of MR/US fusion biopsy, and serving as principal investigator in the development of UroNav/Philips MR/US fusion technology for prostate biopsy and focal therapy planning. He is also a founding executive board member of the Focal Therapy Society and has over 20 years of experience in prostate artery embolization and interventional urology.
Dr. Rastinehad's practice at the urology department at Lenox Hill Hospital provides advanced prostate care for men with elevated PSA, abnormal prostate MRI, localized prostate cancer, enlarged prostate/BPH, urinary symptoms, and complex prostate treatment decisions. Top Doctors are nominated by peer physicians and selected by the physician-led Castle Connolly research team.
Castle Connolly publishes its Top Doctors list at castleconnolly.com and in various print and online partner publications. Nominations are open to all board-certified MDs, DOs, and DPMs. The selection process considers medical education, training, hospital appointments, and disciplinary histories. Doctors cannot pay to be selected.
